


Treatment Resistance in Psychiatry. Risk Factors, Biology, and Management
Kim, Y.
1ª Edición Noviembre 2018
Inglés
Tapa dura
418 pags
1014 gr
18 x 26 x 3 cm
ISBN 9789811043574
Editorial SPRINGER
Recíbelo en un plazo De 2 a 3 semanas
Part I. Rethinking the treatment resistance in psychiatry
Chapter 1. Definition and epidemiology of treatment resistance in psychiatry
Chapter 2. Paradigm shift in study of treatment resistant psychiatric disorder
Chapter 3. Genetic factors underlying treatment resistance in psychiatry
Chapter 4. Using neuroimaging and electroencephalography for prediction of treatment resistance in psychiatric disorders
Chapter 5. Developing therapies for treatment-resistant depressive disorders in animal models
Chapter 6. Integrated approaches to treatment-resistant psychiatric disorders
Part II. Treatment resistance in specific disorders
Chapter 7. Treatment resistant depression: understandings on the neurobiological etiology that lead to novel pharmacological treatment options
Chapter 8. Treatment Resistant Schizophrenia: assessment and management
Chapter 9. Treatment resistance in bipolar disorders
Chapter 10. Treatment resistance in post-traumatic stress disorder
Chapter 11. Treatment resistance in obsessive compulsive disorder
Chapter 12. Treatment of opioid dependence
Chapter 13. Treatment-resistant panic disorder
Chapter 14. Treatment resistance in anxiety disorder: generalized anxiety disorder, social anxiety disorder
Chapter 15. Treatment resistance in Attention-Deficit Hyperactivity Disorder
Chapter 16. Treatment resistance in Tourette syndrome
Chapter 17. Treatment-Resistance Eating Disorders
Chapter 18. Comorbid sleep and wake problems in treatment-resistant psychiatric conditions
Part III. Therapeutic intervention for treatment resistance
Chapter 19. Creative, person-centered psychopharmacology for treatment resistance in psychiatry
Chapter 20. A psychodynamic approach to treatment resistance
Chapter 21. Cognitive behavioral therapy and behavioral activation therapy for treatment resistant depression: traditional and digital therapy perspectives
Chapter 22. Novel neurostimulation therapeutic approaches for treatment resistant psychiatric disorders
Chapter 23. When clozapine fails: augmentation strategies in the management of clozapine-resistant schizophrenia
Chapter 24. Fecal microbiota transplantation in the treatment resistant psychiatric disorders
Chapter 25. Neurosurgical intervention for treatment-resistant psychiatric disorders
This book reviews all the important aspects of treatment-resistant psychiatric disorders, covering issues such as definitions, clinical aspects, neurobiological correlates, treatment options, and predictors of treatment response. The book is divided into three sections, the first of which examines the most recent thinking on treatment resistance in psychiatry, including definition and epidemiology, paradigm shift in the study of the subjects, individual susceptibility and resilience, abnormal structural or functional connectivity, and insights from animal models. The second section then discusses treatment resistance in each of the major psychiatric disorders, with particular focus on the responsible clinical and biological factors and the available management strategies. Finally, more detailed information is presented on diverse pharmacological and non-pharmacological therapeutic interventions. The book, written by leading experts from across the world, will be of value to all who seek a better understanding of the clinical-neurobiological underpinnings and the development of management for treatment resistance in psychiatric disorders.
Yong-Ku Kim, MD, PhDDepartment of Psychiatry, Korea University Ansan Hospital, South Korea
Fax91 448 21 88
DirC / Raimundo Lulio, 1, 28010 Madrid, España.
Mailpedidosweb@axon.esPrivacidadCondiciones de ventaQuiénes SomosAvisoContacto© 2021 Axón Librería S.L.
v1.53.0